MedPath

Phase out as a treatment for chronic untreatable tinnitus: a double blind crossover trial

Completed
Conditions
Tinnitus
Ear, Nose and Throat
Ear disorders
Registration Number
ISRCTN17631678
Lead Sponsor
niversity Medical Centre Groningen (UMCG) (The Netherlands)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
60
Inclusion Criteria

1. Subjects greater than 18 years
2. Unilateral or bilateral tinnitus
3. Predominant tone tinnitus by history
4. Tinnitus for minimum of three months

Exclusion Criteria

1. Acoustic neurinoma
2. Aortic/outflow tract stenosis
3. Pulsatile tinnitus
4. Pregnancy
5. Inability to correct use of test equipment: unable to cooperate during audiologic examination
6. Known tinnitus etiology, which would demand other treatment
7. Hearing loss greater than 60 decibel compared with standardised normal hearing on standard frequencies of a tone audiogram (250, 500, 1000, 2000, 4000 and 8000 hertz)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath